Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JEREMY M SHEFNER

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1184682882
CMS profile
325271
Location
PHOENIX, AZ

General Payments · PY2018–2024

$154,536.28

  • Reported across 99 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$19,838.60

14 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $18,392.50 9
Travel and Lodging $1,322.71 3
Food and Beverage $123.39 2

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $14,919.61 21
PY2019 $10,100.33 18
PY2020 $4,663.00 5
PY2021 $22,528.96 11
PY2022 $38,508.93 20
PY2023 $43,976.85 10
PY2024 $19,838.60 14

Payment records · PY2024 (14)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amylyx Pharmaceuticals, Inc. $30.68 03/04/2024 Food and Beverage Undisputed 01/23/2026 1148254431 CMS
ARGENX US, INC. $287.00 06/05/2024 Consulting Fee Undisputed 01/23/2026 1142112823 CMS
ARGENX US, INC. $1,150.00 06/05/2024 Consulting Fee Undisputed 01/23/2026 1142112863 CMS
E.R. Squibb & Sons, L.L.C. $2,500.00 02/01/2024 Consulting Fee Undisputed 01/23/2026 1101244000 CMS
SANOFI-AVENTIS U.S. LLC $2,727.00 09/25/2024 Consulting Fee Undisputed 01/23/2026 1139601872 CMS
Teva Pharmaceuticals USA, Inc. $1,890.00 01/30/2024 Consulting Fee Undisputed 01/23/2026 1151583653 CMS
VERTEX PHARMACEUTICALS INCORPORATED $2,020.00 01/30/2024 Consulting Fee Undisputed 01/23/2026 1105922607 CMS
VERTEX PHARMACEUTICALS INCORPORATED $92.71 07/30/2024 Food and Beverage Undisputed 01/23/2026 1105903959 CMS
VERTEX PHARMACEUTICALS INCORPORATED $1,035.48 07/30/2024 Travel and Lodging Undisputed 01/23/2026 1105906657 CMS
VERTEX PHARMACEUTICALS INCORPORATED $218.10 07/30/2024 Travel and Lodging Undisputed 01/23/2026 1105912986 CMS
VERTEX PHARMACEUTICALS INCORPORATED $4,788.50 07/30/2024 Consulting Fee Undisputed 01/23/2026 1105913654 CMS
VERTEX PHARMACEUTICALS INCORPORATED $69.13 07/30/2024 Travel and Lodging Undisputed 01/23/2026 1105915720 CMS
VERTEX PHARMACEUTICALS INCORPORATED $1,010.00 09/11/2024 Consulting Fee Undisputed 01/23/2026 1105919138 CMS
VERTEX PHARMACEUTICALS INCORPORATED $2,020.00 11/27/2024 Consulting Fee Undisputed 01/23/2026 1105919856 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.